Fastdol

Quick links to important sections

Fastdol

Treatment option: Pain

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fastdol

What is Fastdol? Overview

Property Description
Active Ingredient Generic analgesic/anti-inflammatory agent
Form Typically Oral Tablet or Topical Gel
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common Use Symptomatic relief of mild-to-moderate pain and inflammation
Origin Synthetically manufactured

What Type of Medicine is Fastdol?

Fastdol is broadly classified as an Analgesic (pain reliever) and is primarily recognized as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This dual functionality is key: it addresses discomfort by both relieving the sensation of pain and reducing the underlying inflammatory processes in the body. It is often positioned as an Over-The-Counter (OTC) product for temporary, accessible relief.

The active ingredients in Fastdol are clinically recognized for their ability to provide temporary relief across a range of common ailments. NSAID compounds are fundamentally effective because they inhibit the synthesis of key inflammatory mediators, known as prostaglandins. As such, the medicine works by interfering directly with the body's primary pain and swelling signals.

What is the Core Composition and Purpose of Fastdol?

The active ingredient in Fastdol is a synthetically derived compound, ensuring reliable potency and consistent pharmaceutical quality. This formula may be offered as a unique-delivery film-coated tablet or a non-greasy topical gel, which differentiates it by focusing on user comfort during administration.

Active ingredients belonging to this class are considered cornerstones in managing acute pain due to their well-documented ability to reduce inflammation. The overall therapeutic goal is to manage common issues, such as pain following minor muscle fatigue or joint stiffness, offering effective relief during the short-term duration of these events.

What side effects are possible with Fastdol?

Possible Side Effects and Safety Information

The official safety profile of Fastdol (a generic Non-Steroidal Anti-Inflammatory Drug, or NSAID) is documented by governmental regulatory agencies and structured by the body systems affected. Adverse reactions are classified by frequency, such as Common, Uncommon, or Rare, as observed in clinical studies and post-market surveillance.

Adverse Reaction Scope

Classification Aspect Description based on Regulatory Labeling
Common Reactions Include gastrointestinal disturbances like dyspepsia, nausea, and abdominal pain, as well as headache and mild fluid retention (edema).
System-Organ Classes Effects are primarily reported in the Gastrointestinal disorders, Vascular disorders, and Renal and urinary disorders categories.

Serious Adverse Reactions and Key Constraints

Regulatory documentation mandates warnings regarding the potential for serious, life-threatening events. These include an increased risk of severe Gastrointestinal bleeding, ulceration, or perforation and serious Cardiovascular thrombotic events (e.g., myocardial infarction and stroke).

Safety constraints and time-related patterns are also outlined. The risk of serious adverse cardiovascular events is stated to increase with longer duration of use and at higher doses. The medicine is contraindicated in specific situations, such as immediately following Coronary Artery Bypass Graft (CABG) surgery and in individuals with active peptic ulcers or severe hepatic or renal failure.

Population-Specific Safety Notes

The label specifies that older adults are at a greater documented risk for serious gastrointestinal adverse events. Furthermore, the use of this class of medicine is constrained during the final stages of pregnancy due to the risk of premature closure of the fetal ductus arteriosus.

Overdose and Emergency Response

Overdose and When to Seek Help

Fastdol is a combination medication containing tramadol (an opioid) and paracetamol (acetaminophen). Overdose symptoms are severe and stem from the effects of both active components.

Immediate medical help is required if an overdose is suspected. Call emergency services immediately if the person is unresponsive, unable to wake up, or not breathing normally.


Documented Overdose Presentations

Component Primary Risk / Manifestation
Tramadol (Opioid) Respiratory depression (slow, weak, or no breathing), profound sedation, coma, miosis (pinpoint pupils), seizures, and death.
Paracetamol (Acetaminophen) Hepatic toxicity (severe liver damage), which may develop over hours to days.

Overdose Severity and Risk Factors

Overdose is considered a life-threatening medical emergency and is explicitly associated with a risk of serious harm, including fatal and non-fatal outcomes. The risk is directly linked to the use of higher doses and is exacerbated when taken alongside other central nervous system (CNS) depressants. Due to the opioid component, a reversal agent like naloxone should be available for prompt administration in an opioid overdose event.

Therapeutic Uses of Fastdol

What Fastdol Treats: Main Uses and Benefits

Fastdol is commonly used to help with symptomatic relief for acute discomfort and associated physical distress, offering short-term support when symptoms become challenging. Medications in this category are broadly applied in situations involving certain distressing symptoms and physical discomfort.

The medication is commonly used to support the management of intense pain symptoms, including those associated with severe headaches, muscle and joint aches, localized discomfort (like toothache), and menstrual pain. It is also relevant in contexts marked by systemic imbalance, such as reducing fever that accompanies colds and flu.

The medication is helpful in situations where multiple symptoms occur together and require supportive management. By addressing both pain and fever symptoms, Fastdol assists with maintaining functional stability when symptoms are more noticeable, supporting general well-being during symptomatic phases.

Quick Fact: Relief for Noticeable Discomfort Fastdol is applied when symptoms create noticeable physiological strain or interfere with daily comfort, offering support during episodes of heightened discomfort.

Regulatory References

  1. MedlinePlus Medical Encyclopedia on Over-the-Counter Pain Relievers

Eligibility and Restrictions for Use

Who Can and Cannot Use Fastdol?

The official eligibility profile for Fastdol, a Non-Steroidal Anti-Inflammatory Drug (NSAID), is strictly defined by regulatory contraindications and population restrictions mandated by authorities like the FDA and EMA.

Populations Who Must Not Use Fastdol (Contraindications)

Fastdol is contraindicated and must not be used by patients with a known hypersensitivity to the active ingredient, aspirin, or any other NSAID. It is also strictly prohibited in individuals with active gastrointestinal (GI) bleeding or peptic ulceration and in those undergoing Coronary Artery Bypass Graft (CABG) surgery. Pregnant women starting at 30 weeks gestation and later (third trimester) are also absolutely ineligible.


Restricted and Conditional Use

Use of Fastdol requires caution and may be limited in several groups. Patients with advanced renal impairment (severe kidney disease) or severe heart failure should avoid the medicine. The drug's safety and effectiveness are often not established in pediatric patients under the age of 18 for the adult indication. Older adults (65 years and over), as well as those with a history of GI ulcers or established cardiovascular disease, require careful consideration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fastdol's interaction profile is officially defined by specific constraints and documented risk amplifications based on regulatory labeling for the Non-Steroidal Anti-Inflammatory Drug (NSAID) class.

Contraindicated Combinations and Restrictions

Use is formally contraindicated in the peri-operative setting of coronary artery bypass graft (CABG) surgery. Co-administration with other NSAIDs or analgesic-dose Aspirin is restricted across regulatory documents due to a significantly increased risk of serious gastrointestinal adverse events, including bleeding and ulceration.

Exposure Alteration and Pharmacodynamic Risk

Official documents note that co-administration can increase the serum concentrations of several medicines, specifically Lithium, Methotrexate, and Digoxin, which may require monitoring. The profile also highlights Pharmacodynamic Risk Amplification: combining Fastdol with Anticoagulants, Corticosteroids, or SSRIs/SNRIs is associated with an increased hazard of bleeding, particularly within the gastrointestinal tract.

Efficacy and Substance Interactions

The antihypertensive effect of certain medicines, including ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), and Diuretics, may be diminished due to documented interaction. Furthermore, co-administration with Alcohol (Ethanol) is noted in regulatory warnings to exacerbate the risk of gastrointestinal bleeding. Population-specific notes emphasize that the Elderly and volume-depleted patients face a heightened risk of adverse renal outcomes in combination with specific antihypertensive agents.

Mechanism of Action

How Fastdol Works

Fastdol's action is defined by a precise biochemical mechanism that modulates the synthesis of key lipid mediators, resulting in defined physiological consequences.

Inhibiting the Enzyme System at the Molecular Core

This mechanism focuses on the immediate biological target: the cyclooxygenase (COX) enzyme system (COX-1 and COX-2). Fastdol acts as a competitive inhibitor, binding to the active site and preventing the conversion of arachidonic acid into prostaglandins. This molecular blockade suppresses the synthesis of these lipid mediators, thereby initiating the resulting mechanistic cascade.

Dampening Peripheral Nociceptive Signaling

The molecular blockade translates into a physiological consequence through modulation of the peripheral nociceptive pathway. By reducing the local concentration of Prostaglandin E2 (PGE2) at the site of tissue damage, the mechanism prevents the chemical lowering of the activation threshold for peripheral nerve endings. This action reduces the sensitivity threshold of peripheral nerve endings, supporting the maintenance of baseline afferent signaling.

Regulating Central Thermoregulation

Systemic consequence of this mechanism involves the modulation of the hypothalamic thermoregulatory center. Inhibition of PGE2 synthesis within the hypothalamus facilitates the normalization of the elevated thermal set-point. This influence on central PGE2 levels modifies the systemic cascade of inflammatory mediators, contributing to a functional adjustment of body temperature regulation.

Dosage and Administration Information

Official Administration Guidelines for Fastdol

Fastdol is used according to specific, non-advisory instructions detailed in official regulatory documentation. The product's usage is defined by its approved routes and precise dosage limitations, emphasizing a short-term, as-needed approach.

Administration Scope Official Requirement
Route of Administration Administered via the oral route (tablets) or topically (gel) for local application.
Standard Adult Oral Dosing Initial and single doses are typically 200 mg to 400 mg. Regulatory labeling restricts the daily dose to a maximum of 1200 mg for over-the-counter use, though higher amounts (e.g., up to 3200 mg per 24 hours) may be specified for prescription-monitored use.
Frequency and Timing Administration is intermittent (as needed) with tablets typically taken every 4 to 6 hours. Oral administration is recommended with food or milk to facilitate proper intake.
Duration Pattern Use is defined as short-term, typically not extending beyond 10 days for oral non-prescription use, as stated in the official guidance.
Population Adjustments For older adults or those with hepatic/renal impairment, official documents specify that the lowest effective dose should be initiated and maintained.

Procedural and Contextual Requirements

Oral administration requires the tablet to be administered whole, using the smallest effective amount for the shortest required period. For the topical gel, the preparation involves ensuring the skin is clean and dry, followed by gently rubbing the required amount into the affected area, and washing hands completely after application. Missed doses should not be corrected by taking a double amount at the next scheduled time.

Recent Clinical Evidence

Fastdol: Recent Clinical Evidence

Clinical research on Fastdol, studied as a non-steroidal anti-inflammatory drug (NSAID), focuses on its profile for managing pain and inflammation.


Research Focus on Pain and Inflammation

Research has examined Fastdol's potential for use in individuals with acute pain, such as from sprains and muscle tears. The research generally centers on the compound's effect on inflammatory processes and pain signals.

  • A key meta-analysis reported changes in patient-reported pain scores (VAS) compared to placebo. The observation was made within the first 24 hours of the study administration across several doses.
  • Furthermore, a large randomized controlled trial (RCT) compared the compound's effect on pain intensity with that of standard aspirin. This trial involved participants with post-surgical pain over three days.
  • Early trials evaluated changes in swelling over a 7-day course. These trials primarily focused on inflammatory markers following soft tissue injury.

Pharmacologic Profile and Specific Studies

Fastdol is typically grouped as an NSAID. Studies have focused on the compound's inhibitory effect on cyclooxygenase (COX) enzymes. This action is associated with its anti-inflammatory and pain-relieving properties.

Pharmacokinetic research measured the compound's half-life to be approximately 4 hours.

  • A study involving older adults (over 65) with osteoarthritis examined the compound's profile over four weeks. In this study, the occurrence of adverse events was noted to be low, though follow-up was limited.
  • Research has explored whether the combination of Fastdol with a local anesthetic affects the speed of recovery in minor surgical settings. These studies focused on patients undergoing procedures like wisdom tooth extraction.
  • An analysis of post-marketing data reported an association between higher doses and the incidence of gastrointestinal discomfort.

Key Studies & References

  1. Paracetamol Product Information - Therapeutic Goods Administration (TGA) (Pharmacokinetic Data/Half-life)
  2. Gastrointestinal injury associated with NSAID use: a case study and re (Review of NSAID GI risk/dose correlation)

Frequently Asked Questions (FAQ)

Common questions about Fastdol (FAQ)

Q: How long does it usually take for Fastdol to start working?

According to official pharmacokinetic profiles, Fastdol is absorbed rapidly. Studies indicate that the onset of noticeable pain relief is typically experienced within 30 to 60 minutes after taking the oral form. The actual time it takes to feel relief may vary among individuals and the specific condition being managed.

Q: What is Fastdol commonly prescribed for, besides the main use?

Official drug labeling for this medicine's class includes several indications beyond general pain relief. These often include the symptomatic relief of acute conditions like dysmenorrhea (menstrual pain). The drug is also described as effective in managing pain and inflammation related to specific conditions such as osteoarthritis.

Q: Is it possible to feel dizzy after taking Fastdol?

Yes, regulatory information lists dizziness as a potential side effect, though it is not classified among the most common adverse reactions. Official safety documents mention that Fastdol, like other NSAIDs, can affect the central nervous system.

Q: Can Fastdol affect sleep or cause drowsiness?

Regulatory documents report potential effects on the central nervous system. These can include both drowsiness (feeling sleepy) and insomnia (difficulty sleeping) as documented side effects of this drug class.

Q: Is Fastdol safe for people who have kidney issues?

Official safety information states that the medicine is contraindicated, meaning it must not be used, by patients with severe kidney failure. For people with less severe kidney impairment, regulatory labels specify that the lowest effective amount should be used for the shortest possible time. Use in this population is described as requiring careful medical consideration.

Q: Can taking Fastdol make skin more sensitive to the sun?

Yes, official safety information for this class of medicine may include a warning about photosensitivity. This means the skin could have an increased sensitivity to sunlight or other sources of ultraviolet (UV) light.

Q: Does Fastdol interact with common supplements like vitamins or herbal products?

Regulatory warnings concerning interactions are typically focused on other prescription drugs. However, certain herbal supplements, such as Ginger, Garlic, or Ginkgo, have been noted to potentially increase the risk of bleeding or kidney problems when used with an NSAID. Official drug documentation describes the need to review all substances before use.

Q: Is Fastdol generally considered non-addictive?

As a non-opioid Non-Steroidal Anti-Inflammatory Drug (NSAID), Fastdol is not classified as a controlled substance by major regulatory bodies. This classification indicates that the drug does not carry the same risk of physical dependence or addiction associated with opioid pain relievers.

Q: Can Fastdol cause changes in appetite?

Loss of appetite, also referred to as anorexia or decreased appetite, is documented in the official adverse reaction profile for this drug class. This change in appetite is generally noted as an uncommon side effect.

Q: Why is it important to check for drug interactions with Fastdol?

Official regulatory documents emphasize checking for interactions because combining Fastdol with certain medicines creates a risk of harm. This co-administration can either significantly increase the risk of serious side effects (such as bleeding or kidney damage) or it can reduce the effectiveness of the other medicine (like specific blood pressure drugs).

Q: What is the difference between Fastdol and generic versions of the drug?

Regulatory agencies require that generic versions must be bioequivalent to the brand-name drug. This means they must contain the identical active ingredient, strength, and dosage form and perform the same way in the body. The main difference typically lies in the inactive ingredients (e.g., color, flavor, fillers).

Q: What are the most common reasons why people stop using Fastdol?

Evidence from clinical trials indicates that the most common reasons for people stopping the use of this drug class are generally linked to gastrointestinal side effects. These frequently reported adverse reactions include nausea, dyspepsia, or general stomach pain.

Q: How does the way Fastdol works differ from a medicine like Aspirin?

Both medicines work by inhibiting the COX enzyme. However, regulatory documents describe that Aspirin's inhibition of the COX-1 enzyme is usually irreversible, leading to a long-lasting effect on blood clotting. In contrast, Fastdol's effect on the enzyme is generally reversible and temporary.

Q: Is it normal to feel a bit restless after taking Fastdol?

Restlessness, sometimes described as agitation, is listed in the official adverse reaction profile of some NSAID labels. This effect is described as an uncommon reaction affecting the nervous system.

Q: Are there any known issues with Fastdol and driving or operating machinery?

Regulatory labeling advises caution when engaging in activities like driving or operating machinery. This warning is based on the potential for Fastdol to cause side effects such as dizziness or drowsiness. Official documents caution that these effects may impair a person's ability to drive or operate machinery.

Q: What is the typical timeframe before a decision is made to continue or stop Fastdol?

For non-prescription use, regulatory guidelines typically limit the duration to a maximum of 10 days for pain relief. If symptoms continue after this short duration, official guidance recommends stopping use. In such cases, further medical evaluation is generally advised.

Q: What are the main research findings that support the use of Fastdol?

The core research findings support the use of Fastdol for pain relief and the reduction of inflammation. Clinical studies report its effectiveness, often in comparison to a placebo, in significantly improving patient-reported pain scores in models of acute pain.

Q: What are the requirements for stopping Fastdol once started?

Official documents state that stopping the medicine is required when the maximum short-term duration (e.g., 10 days for OTC use) is reached. Regulatory documents describe that the development of any serious adverse events (such as signs of internal bleeding, severe allergic reactions, or heart issues) requires the medicine to be immediately stopped.

Q: Is Fastdol safe to use during breastfeeding?

Official product information for this class of NSAID generally advises that only small amounts pass into breast milk. Regulatory guidance usually states that it is considered compatible with breastfeeding for short-term use, and review of use with a healthcare professional is recommended.

How should Fastdol be stored and disposed of?

How to Store and Dispose of Fastdol?

Official regulatory guidelines define specific conditions for storing and disposing of Fastdol to maintain its quality and ensure safety.

️ Storage Requirements

Condition Requirement (Based on Regulatory Labeling)
Temperature Store below 25 C (at controlled room temperature).
Protection Keep the medicine protected from moisture and direct light exposure.
Packaging Must be kept in the original package, with blister strips remaining in the outer carton.
Inaccessibility Keep this medicine out of the sight and reach of children at all times.

️ Disposal Instructions

Fastdol must not be discarded with household waste or disposed of via wastewater, as per environmental guidelines for medicinal products. For proper disposal of expired or unused medication, consult a pharmacist regarding local return or collection programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fastdol found in:

A-Z Index: